The proposed role for RelB in laryngeal cancer is in line with other mechanistic studies that indicate it to be a promoter of oncogenic transcription and stemness in tumor initiating cells of colon cancers, gliomas, lymphomas, and myelomas [40–43]. This evidence concerns the gene RELB and central nervous system cancer.